Hironobu Suto, Hiroyuki Matsukawa, Takuro Fuke, Mina Nagao, Yasuhisa Ando, Minoru Oshima, Hiroki Yamana, Hideki Kamada, Hideki Kobara, Hiroyuki Okuyama, et al. Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant chemoradiotherapy for resectable pancreatic cancer: A retrospective study. Pancreatology. 2024. 24. 3. 431-436
Yudai Sato, Tomoko Tadokoro, Hiroki Yamana, Hiraki Akai, Kei Takuma, Naoki Fujita, Mai Nakahara, Kyoko Oura, Koji Fujita, Joji Tani, et al. Hepatocellular carcinoma treated with radical resection after endoscopic diagnosis of the extent of bile duct invasion: A case report. DEN open. 2024. 4. 1. e265
Hironobu Suto, Hiroyuki Matsukawa, Yasuhisa Ando, Minoru Oshima, Takuro Fuke, Mina Nagao, Hiroki Yamana, Hideki Kamada, Kensuke Kumamoto, Keiichi Okano. Predictive role of the prognostic nutritional index in patients with pancreatic ductal adenocarcinoma who underwent neoadjuvant chemoradiotherapy followed by curative pancreatic resection: A retrospective study using prospectively collected data. Journal of Hepato-Biliary-Pancreatic Sciences. 2024
Hironobu Suto, Takuro Fuke, Hiroyuki Matsukawa, Yasuhisa Ando, Minoru Oshima, Mina Nagao, Shigeo Takahashi, Toru Shibata, Hiroki Yamana, Hideki Kamada, et al. Short- and Long-Term Outcomes of Neoadjuvant Chemoradiotherapy Followed by Pancreatoduodenectomy in Elderly Patients with Resectable and Borderline Resectable Pancreatic Cancer: A Retrospective Study. Journal of Clinical Medicine. 2024. 13. 5. 1216-1216
Mina Nagao, Minoru Oshima, Hironobu Suto, Masahiro Sugimoto, Ayame Enomoto, Tomomasa Murakami, Ayaka Shimomura, Yukiko Wada, Hiroyuki Matsukawa, Yasuhisa Ando, et al. Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Ductal Adenocarcinoma. Pancreas. 2024. 53. 4. e301-e309